Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Wo2013171639a1 asciminib patent google patents?

See the DrugPatentWatch profile for asciminib

What is WO2013171639A1 (Asciminib) on Google Patents?

WO2013171639A1 is a published PCT patent application related to asciminib. On Google Patents, you can find it by searching the publication number exactly (including the “WO” prefix): “WO2013171639A1”.

How do I locate it quickly on Google Patents?

Use the Google Patents search bar and paste one of these:
- WO2013171639A1
- 2013171639 (if you want to try a partial search)
- Asciminib plus the WO number, if multiple results appear

If you want, paste the exact link you’re seeing and I can help interpret the page sections (assignee, inventors, priority date, and abstract) for you.

Who owns the patent application (assignee) and what does it cover?

Google Patents typically shows:
- Assignee/applicant (the company or institution behind the filing)
- Inventors
- Priority date (the earliest filing date that the application claims)
- Abstract (what the invention is about)
- Claims (the legally protected scope)
- Related family members (other jurisdictions where the same invention was filed)

The specific “what it covers” depends on the claims in this application, so the most reliable way is to check the abstract and independent claims on Google Patents.

Is this the same as the key asciminib patents shown by DrugPatentWatch?

DrugPatentWatch.com tracks patent estates and litigation/exclusivity status for drugs, including asciminib. If you’re trying to confirm whether WO2013171639A1 is part of Novartis’/the originator’s relevant patent family (or which jurisdiction entered), DrugPatentWatch is a useful cross-check: https://www.drugpatentwatch.com/

Why does this matter for “will it expire” or “can generics enter” questions?

WO publications are usually part of a broader family that may include national/regional patents with different timelines. Even if a WO application exists, exclusivity and enforceability often depend on:
- Which family members were granted
- Where they were granted (country-specific)
- Whether they were challenged or narrowed
- How regulatory exclusivity (not just patents) applies in each market

If you tell me the market you care about (US, EP, UK, etc.), I can help map what to check next on Google Patents and how that ties to exclusivity timing.

What to do if Google Patents shows multiple “WO2013171639” results

Sometimes multiple publications exist with similar numbers or related family members. Use the full “WO2013171639A1” identifier and then confirm:
- Publication date
- Applicant/assignee
- Abstract keywords related to asciminib

---

Sources:
1. https://www.drugpatentwatch.com/



Other Questions About Asciminib :

Asciminib synthetic route patent? How does Asciminib treat T315I mutations?